leisure time -WSS

leisure time

author：focus 2025-09-07 06:37:34 - browse：7

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Will Ozempic

WSS

First Opinion Podcast: Long Covid needs a new approach

Beam Therapeutics to lay off 20% of its staff, re

Medicare reduced heart disease by changing how it pays doctors

Chamber of Commerce, DOJ clash in court over drug prices

White House Covid adviser calls on docs to combat misinformation

First Opinion Podcast: Long Covid needs a new approach

Wikipedia

leisure time

leisure time

Walensky prepares to leave CDC — and Congress — behind

Eli Lilly expects to double planned employment in Boston center

DIEP, the 'gold standard' of breast reconstruction, is under threat

House panel takes first step toward fixing drug shortages

Malaria cases in Florida and Texas: Here’s what you need to know

First Opinion Podcast: Long Covid needs a new approach

Medical leaders decry Supreme Court decision on affirmative action

Researchers explore possible ties between long Covid, menopause

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Free Covid tests will again be offered to all U.S. households

knowledge

Midwives could help bridge maternal health disparities in the U.S.

STAT Summit: GSK CEO on pharma giant's new direction

How climate

Solve the antibiotic resistance crisis with preventive drugs

Patients, doctors press FTC to beef up hospital merger scrutiny

Neurocrine congenital adrenal hyperplasia trial succeeds

focus

focus

focus

Wikipedia